13F-HR filed by Tri Locum Partners LP
Tri Locum Partners LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 25 holding rows worth $395,498,528.
- Accession
- 0001826434-24-000006
- Filer
- CIK 1826434
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 25 entries on the cover page, a total value of $395,498,528 stated on the cover page (in dollars after the unit check, H1), rows summing to $395,498,528 with VALUE read as dollars as filed, 13F file number 028-21000. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 2,550,307 | $41,442,489 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 74,558 | $32,062,922 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 227,762 | $31,062,182 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 82,271 | $25,705,574 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 230,585 | $24,970,050 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 306,513 | $24,674,297 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 316,501 | $21,205,567 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 335,514 | $19,852,363 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 17,516 | $18,409,841 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 65,352 | $18,309,016 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 133,276 | $17,836,327 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 1,189,518 | $16,724,623 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 596,919 | $16,701,794 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 50,100 | $15,959,355 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 356,532 | $15,790,802 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 45,000 | $10,935,000 | dollars as filed | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 565,422 | $10,369,839 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 63,811 | $9,108,382 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 113,344 | $8,558,605 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 101,959 | $3,975,381 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 514,642 | $3,520,151 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 75,319 | $3,115,194 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 382,055 | $2,754,617 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 71,428 | $2,419,266 | dollars as filed | |
| FEMASYS INC | 31447E105 | cs | 30,606 | $34,891 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001826434-24-000006 | this filing | 2024-08-14 | acceptance time not in the bulk data set |